MDM2 and melanoma: Several functional MDM2/MDM4 SNPs in high LD with variants tested in our melanoma cohort modulate expression in skin and in distal organs—to where melanoma often spreads—affecting molecules that have been previously associated with tumor progression, resistance to chemotherapy, and prognosis in gynecological cancers, among others.